{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EPOCH+II&page=17", "query": { "intervention": "EPOCH II", "page": 17 }, "page_size": 10 }, "pagination": { "page": 17, "page_size": 10, "total_count": 887, "total_pages": 89, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EPOCH+II&page=18&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=EPOCH+II&page=16&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-15T21:01:31.163Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00616109", "title": "Sunitinib Maintenance Therapy After Induction Platinum-Based Chemotherapy in Patients With ES-SCLC", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Extensive-Stage Small Cell Lung Cancer" ], "interventions": [ { "name": "sunitinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Michigan Rogel Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 16, "start_date": "2007-09", "completion_date": "2011-01", "has_results": true, "last_update_posted_date": "2014-04-21", "last_synced_at": "2026-11-15T21:01:31.163Z", "location_count": 1, "location_summary": "Ann Arbor, Michigan", "locations": [ { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00616109" }, { "nct_id": "NCT02799381", "title": "A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Parkinson's Disease (PD)" ], "interventions": [ { "name": "Optimized antiparkinsonian treatment", "type": "DRUG" }, { "name": "Levodopa-Carbidopa Intestinal Gel (LCIG)", "type": "DRUG" }, { "name": "CADD-Legacy ambulatory infusion pump", "type": "DEVICE" }, { "name": "Percutaneous endoscopic gastrostomy tube", "type": "DEVICE" }, { "name": "Jejunal extension tube", "type": "DEVICE" } ], "intervention_types": [ "DRUG", "DEVICE" ], "sponsor": "AbbVie", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "30 Years", "maximum_age": null, "sex": "ALL", "summary": "30 Years and older" }, "enrollment_count": 63, "start_date": "2017-02-09", "completion_date": "2019-09-19", "has_results": true, "last_update_posted_date": "2020-08-18", "last_synced_at": "2026-11-15T21:01:31.163Z", "location_count": 2, "location_summary": "Port Charlotte, Florida • Round Rock, Texas", "locations": [ { "city": "Port Charlotte", "state": "Florida" }, { "city": "Round Rock", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT02799381" }, { "nct_id": "NCT01550315", "title": "Effect of Dietary Sodium Intake on Vascular Endothelium", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Postural Tachycardia Syndrome (POTS)" ], "interventions": [ { "name": "Pulsitile Arterial Tonometry (PAT) Protocol", "type": "PROCEDURE" }, { "name": "Calf Blood Flow in Reactive Hyperemia (CBF-RH)", "type": "DEVICE" }, { "name": "Evaluation of Forearm-Mediated Dilation", "type": "DEVICE" } ], "intervention_types": [ "PROCEDURE", "DEVICE" ], "sponsor": "Vanderbilt University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 27, "start_date": "2012-04", "completion_date": "2021-09", "has_results": true, "last_update_posted_date": "2022-01-05", "last_synced_at": "2026-11-15T21:01:31.163Z", "location_count": 1, "location_summary": "Nashville, Tennessee", "locations": [ { "city": "Nashville", "state": "Tennessee" } ], "official_url": "https://clinicaltrials.gov/study/NCT01550315" }, { "nct_id": "NCT03828747", "title": "A Study of Semorinemab in Patients With Moderate Alzheimer's Disease", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Alzheimer's Disease" ], "interventions": [ { "name": "Semorinemab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "[18F]GTP1", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Genentech, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "50 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "50 Years to 85 Years" }, "enrollment_count": 272, "start_date": "2019-01-25", "completion_date": "2023-08-30", "has_results": true, "last_update_posted_date": "2024-09-24", "last_synced_at": "2026-11-15T21:01:31.163Z", "location_count": 31, "location_summary": "Garden Grove, California • Los Alamitos, California • Palo Alto, California + 28 more", "locations": [ { "city": "Garden Grove", "state": "California" }, { "city": "Los Alamitos", "state": "California" }, { "city": "Palo Alto", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "New Haven", "state": "Connecticut" } ], "official_url": "https://clinicaltrials.gov/study/NCT03828747" }, { "nct_id": "NCT04431258", "title": "ABTL0812 in Combination With FOLFIRINOX for First-line Treatment of Metastatic Pancreatic Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Pancreatic Cancer" ], "interventions": [ { "name": "ABTL0812", "type": "DRUG" }, { "name": "Folfirinox", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Ability Pharmaceuticals SL", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2021-05-06", "completion_date": "2024-01-10", "has_results": false, "last_update_posted_date": "2024-03-18", "last_synced_at": "2026-11-15T21:01:31.163Z", "location_count": 4, "location_summary": "Los Angeles, California • Westwood, Kansas • Boston, Massachusetts + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Westwood", "state": "Kansas" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT04431258" }, { "nct_id": "NCT03800134", "title": "A Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients With Resectable Non-small Cell Lung Cancer", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "Durvalumab", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" }, { "name": "Carboplatin", "type": "DRUG" }, { "name": "Cisplatin", "type": "DRUG" }, { "name": "Pemetrexed", "type": "DRUG" }, { "name": "Paclitaxel", "type": "DRUG" }, { "name": "Gemcitabine", "type": "DRUG" }, { "name": "Surgery", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "OTHER", "PROCEDURE" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "120 Years", "sex": "ALL", "summary": "18 Years to 120 Years" }, "enrollment_count": 825, "start_date": "2018-12-06", "completion_date": "2028-09-11", "has_results": false, "last_update_posted_date": "2025-06-11", "last_synced_at": "2026-11-15T21:01:31.163Z", "location_count": 31, "location_summary": "Phoenix, Arizona • Duarte, California • Orange, California + 25 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Duarte", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Aurora", "state": "Colorado" }, { "city": "Boca Raton", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03800134" }, { "nct_id": "NCT02087423", "title": "A Global Study to Assess the Effects of MEDI4736 (Durvalumab) in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Non-Small Cell Lung Cancer" ], "interventions": [ { "name": "MEDI4736", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 446, "start_date": "2014-02-25", "completion_date": "2025-03-26", "has_results": true, "last_update_posted_date": "2026-04-06", "last_synced_at": "2026-11-15T21:01:31.163Z", "location_count": 28, "location_summary": "Goodyear, Arizona • Santa Rosa, California • New Haven, Connecticut + 22 more", "locations": [ { "city": "Goodyear", "state": "Arizona" }, { "city": "Santa Rosa", "state": "California" }, { "city": "New Haven", "state": "Connecticut" }, { "city": "Port Saint Lucie", "state": "Florida" }, { "city": "Tampa", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02087423" }, { "nct_id": "NCT04107077", "title": "Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gastric Cancer", "Peritoneal Carcinomatosis" ], "interventions": [ { "name": "Cisplatin", "type": "DRUG" }, { "name": "Mitomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 21, "start_date": "2025-09-09", "completion_date": "2026-12-20", "has_results": false, "last_update_posted_date": "2026-09-08", "last_synced_at": "2026-11-15T21:01:31.163Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT04107077" }, { "nct_id": "NCT02008656", "title": "Trial Evaluating 3-year Disease Free Survival in Patients With Locally Advanced Rectal Cancer Treated With Chemoradiation Plus Induction or Consolidation Chemotherapy and Total Mesorectal Excision or Non-operative Management", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rectal Cancer" ], "interventions": [ { "name": "Oxaliplatin (OXAL)", "type": "DRUG" }, { "name": "5-Fluorouracil (5-FU)", "type": "DRUG" }, { "name": "Leucovorin", "type": "DRUG" }, { "name": "Capecitabine (Xeloda®)", "type": "DRUG" }, { "name": "intensity modulated radiotherapy (IMRT)", "type": "RADIATION" }, { "name": "Quality of Life Questionnaires", "type": "BEHAVIORAL" }, { "name": "DRE-Endoscopy", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "RADIATION", "BEHAVIORAL", "PROCEDURE" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 358, "start_date": "2013-11", "completion_date": "2026-11", "has_results": false, "last_update_posted_date": "2026-08-24", "last_synced_at": "2026-11-15T21:01:31.163Z", "location_count": 26, "location_summary": "Irvine, California • Orange, California • San Francisco, California + 22 more", "locations": [ { "city": "Irvine", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "San Francisco", "state": "California" }, { "city": "Walnut Creek", "state": "California" }, { "city": "Aurora", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT02008656" }, { "nct_id": "NCT05333029", "title": "Extracorporeal Photopheresis and Mesenchymal Stem Cell Infusion for GVHD", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Graft Versus Host Disease" ], "interventions": [ { "name": "Allogeneic mesenchymal stromal cells (MSCs)", "type": "BIOLOGICAL" }, { "name": "Extracorporeal photopheresis (ECP)", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Molly Gallogly", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2024-10-01", "completion_date": "2025-06-01", "has_results": false, "last_update_posted_date": "2025-01-07", "last_synced_at": "2026-11-15T21:01:31.163Z", "location_count": 1, "location_summary": "Cleveland, Ohio", "locations": [ { "city": "Cleveland", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT05333029" } ] }